Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:853-859

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasenstab, D.
Right arrow Articles by Clowes, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasenstab, D.
Right arrow Articles by Clowes, A. W.
Related Collections
Right arrow Animal models of human disease
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:853.)
© 2000 American Heart Association, Inc.


Thrombosis

Local Plasminogen Activator Inhibitor Type 1 Overexpression in Rat Carotid Artery Enhances Thrombosis and Endothelial Regeneration While Inhibiting Intimal Thickening

David Hasenstab; Holly Lea; Alexander W. Clowes

From the Department of Surgery, University of Washington, School of Medicine, Seattle.

Correspondence to Dr Alexander W. Clowes, University of Washington, Department of Surgery, Box 356410, Seattle, WA 98195-6410. E-mail clowes{at}u.washington.edu

Abstract—Elevated levels of plasminogen activator inhibitor type 1 (PAI-1) are found in advanced atherosclerotic plaque compared with normal vessel and may contribute to plaque progression and complications associated with plaque rupture. Increased expression of PAI-1 probably contributes to the thrombotic properties of advanced atherosclerotic plaque by impeding plasmin generation and degradation of fibrin. To test this hypothesis, we have deliberately created synthetic neointimas by seeding onto the denuded luminal surface of rat carotid arteries smooth muscle cells transduced with replication-defective retrovirus encoding rat PAI-1. This cell-based gene transfer method results in stable, long-term, and localized gene expression. PAI-1 overexpression increases mural thrombus accumulation at 4 days but decreases neointimal area by 30% and 25% at 1 week and 2 weeks, respectively. PAI-1 overexpression accelerates reendothelialization of injured arteries compared with control arteries at 1 week, 2 weeks, and 1 month. PAI-1 overexpression does not alter matrix accumulation at 1 week. Increased PAI-1 expression in the rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening. These results suggest that PAI-1 could play a direct role in the development of advanced atherosclerotic plaque and in the repair of the diseased vessel after fibrous cap disruption.


Key Words: plasminogen activator inhibitor type 1 • carotid arteries • thrombosis • fibrinolysis • endothelium




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
E. M. Kairuz, M. N. Barber, C. R. Anderson, M. Kanagasundaram, G. R. Drummond, and R. L. Woods
C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo
Cardiovasc Res, June 1, 2005; 66(3): 574 - 582.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H.-C. Chen and E. P. Feener
MEK1,2 response element mediates angiotensin II--stimulated plasminogen activator inhibitor-1 promoter activation
Blood, April 1, 2004; 103(7): 2636 - 2644.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. de Waard, E. K. Arkenbout, P. Carmeliet, V. Lindner, and H. Pannekoek
Plasminogen Activator Inhibitor 1 and Vitronectin Protect Against Stenosis in a Murine Carotid Artery Ligation Model
Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 1978 - 1983.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Tanaka, H. Koyama, T. Ichii, A. Shioi, M. Hosoi, E. W. Raines, and Y. Nishizawa
Fibrillar Collagen Regulation of Plasminogen Activator Inhibitor-1 Is Involved in Altered Smooth Muscle Cell Migration
Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1573 - 1578.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Peng, N. Bhatia, A. C. Parker, Y. Zhu, and W. P. Fay
Endogenous Vitronectin and Plasminogen Activator Inhibitor-1 Promote Neointima Formation in Murine Carotid Arteries
Arterioscler Thromb Vasc Biol, June 1, 2002; 22(6): 934 - 939.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. Manganaro, M. Ruggeri, G. Ando, M. Longo, and G. Vita
Endothelial Functions in Pathophysiology of Thrombosis and Fibrinolysis: Late Spontaneous Recanalization of an Occluded Internal Carotid Artery: A Case Report
Angiology, January 1, 2002; 53(1): 99 - 103.
[Abstract] [PDF]


Home page
CirculationHome page
M. B. DeYoung, C. Tom, and D. A. Dichek
Plasminogen Activator Inhibitor Type 1 Increases Neointima Formation in Balloon-Injured Rat Carotid Arteries
Circulation, October 16, 2001; 104(16): 1972 - 1971.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. A. Ploplis, I. Cornelissen, M. J. Sandoval-Cooper, L. Weeks, F. A. Noria, and F. J. Castellino
Remodeling of the Vessel Wall after Copper-Induced Injury Is Highly Attenuated in Mice with a Total Deficiency of Plasminogen Activator Inhibitor-1
Am. J. Pathol., January 1, 2001; 158(1): 107 - 117.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. T. Eitzman, R. J. Westrick, Z. Xu, J. Tyson, and D. Ginsburg
Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery
Blood, December 15, 2000; 96(13): 4212 - 4215.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. H. Gibbons and M. J. Pollman
Death Receptors, Intimal Disease, and Gene Therapy : Are Therapies That Modify Cell Fate Moving too Fas?
Circ. Res., May 26, 2000; 86(10): 1009 - 1012.
[Full Text] [PDF]


Home page
Circ. Res.Home page
A. Gorlach, I. Diebold, V. B. Schini-Kerth, U. Berchner-Pfannschmidt, U. Roth, R. P. Brandes, T. Kietzmann, and R. Busse
Thrombin Activates the Hypoxia-Inducible Factor-1 Signaling Pathway in Vascular Smooth Muscle Cells : Role of the p22phox-Containing NADPH Oxidase
Circ. Res., July 6, 2001; 89(1): 47 - 54.
[Abstract] [Full Text] [PDF]